12 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Central University of Punjab
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
University of Manchester
Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.
National Center For Advancing Translational Sciences
Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).
Purdue University
Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.
Boston University
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Russian Academy of Sciences
Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity
University of Pittsburgh
Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.
Universidade De Lisboa
Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.
Indiana University School of Medicine
Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.
University of Pittsburgh
Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids.
The Johns Hopkins University